NCT04709185View on ClinicalTrials.gov

AVS After 1mg DST to Determine Subtype in PA

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

October 30, 2022

Study Completion Date

December 30, 2022

Conditions
Primary Aldosteronism
Interventions
DRUG

Dexamethasone 1 MG Oral Tablet

oral 1 mg dexamethasone at 23:00-24:00 the night before AVS

DRUG

Placebo

oral placebo at 23:00-24:00 the night before AVS

Trial Locations (1)

Unknown

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT04709185 - AVS After 1mg DST to Determine Subtype in PA | Biotech Hunter | Biotech Hunter